Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H10ClN3O3 |
Molecular Weight | 315.711 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
InChI
InChIKey=DGBIGWXXNGSACT-UHFFFAOYSA-N
InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)
Molecular Formula | C15H10ClN3O3 |
Molecular Weight | 315.711 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:55:06 UTC 2023
by
admin
on
Sat Dec 16 16:55:06 UTC 2023
|
Record UNII |
5PE9FDE8GB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175694
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
WHO-VATC |
QN03AE01
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
243507
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
WHO-ATC |
N03AE01
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
NDF-RT |
N0000007542
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
DEA NO. |
2737
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
LIVERTOX |
NBK548030
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
82794
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2802
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
CLONAZEPAM
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
100000084528
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
2598
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | RxNorm | ||
|
703
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
179913
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
Clonazepam
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
5PE9FDE8GB
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
DB01068
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
1622-61-3
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
D002998
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
1140305
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
3756
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
m3649
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | Merck Index | ||
|
216-596-2
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
DTXSID1022845
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
2765
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
C28935
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
5PE9FDE8GB
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
SUB06728MIG
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
CHEMBL452
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
3265
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY | |||
|
6963
Created by
admin on Sat Dec 16 16:55:07 UTC 2023 , Edited by admin on Sat Dec 16 16:55:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->POSITIVE ALLOSTERIC MODULATOR (PAM) |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MAXIMUM TOLERATED DOSE | TOXICITY |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
PROTEIN BINDING | PHARMACOKINETIC |
|
|
|||
Route of Elimination | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||